Skip to main content

West Pharmaceutical Services free cash flow

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

West Pharmaceutical Services's free cash flow was $469 million for fiscal year 2025 (the twelve months to 31 Dec 2025), up 69.6% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was $150 million, up 12.3% from a year earlier.

Over the four quarters to 30 Sep 2026, free cash flow was $453 million.

From West Pharmaceutical Services's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 29 Oct 2026.

Fiscal 2025
$469M
+69.6%
Q3 FY2026
$150M
+12.3% on a year
Growth over 9 years
+28.5%
a year, FY 2016–FY 2025

Free cash flow by fiscal year

$49.2MFY 2016$133MFY 2017+169%$184MFY 2018+38.8%$241MFY 2019+30.9%$298MFY 2020+23.8%$331MFY 2021+10.9%$439MFY 2022+32.9%$415MFY 2023−5.7%$276MFY 2024−33.3%$469MFY 2025+69.6%

Change on the year before, under each year. From FY 2016 to FY 2025, West Pharmaceutical Services's free cash flow went from $49.2 million to $469 million, a compound annual change of +28.5%; FY 2025 is the highest of the period.

West Pharmaceutical Services free cash flow, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Free cash flow$49.2M$133M$184M$241M$298M$331M$439M$415M$276M$469M
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Free cash flow by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

West Pharmaceutical Services free cash flow, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Free cash flow$85.2M$58.1M$102M$134M$175M$47.2M$80.8M$150M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How free cash flow is measured

Free cash flow is the cash generated by operations less capital expenditure: the cash a company has left to repay debt, pay dividends, buy back shares or invest. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

West Pharmaceutical Services's other figures

Free cash flow of comparable companies

Everything on WST, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.